Cargando…
Hyaluronan Synthase and Hyaluronidase Expression in Serous Ovarian Carcinoma is Related to Anatomic Site and Chemotherapy Exposure
The present study investigated the expression and clinical role of hyaluronan synthases (HAS1-3) and hyaluronidases (Hyal1-3) in serous ovarian carcinoma. HAS and HYAL mRNA expression was analyzed in 97 tumors (61 effusions, 27 primary carcinomas, 9 solid metastases) using PCR and further studied fo...
Autores principales: | Weiss, Ilana, Trope, Claes G., Reich, Reuven, Davidson, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497304/ https://www.ncbi.nlm.nih.gov/pubmed/23202930 http://dx.doi.org/10.3390/ijms131012925 |
Ejemplares similares
-
Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012) -
The Role of the Tumor Stroma in Ovarian Cancer
por: Davidson, Ben, et al.
Publicado: (2014) -
Expression of Hyaluronan Synthases (HAS1–3) and Hyaluronidases (HYAL1–2) in Serous Ovarian Carcinomas: Inverse Correlation between HYAL1 and Hyaluronan Content
por: Nykopp, Timo K, et al.
Publicado: (2009) -
Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
por: Nykopp, Timo K, et al.
Publicado: (2010) -
Inverse expression of hyaluronidase 2 and hyaluronan synthases 1–3 is associated with reduced hyaluronan content in malignant cutaneous melanoma
por: Hanna, Siiskonen, et al.
Publicado: (2013)